Present indication and therapeutic strategies of ALK inhibitors in lung cancer

Date 25 November 2018
Event ESMO Asia 2018 Congress
Session ESMO-AACR: ALK gene fusions: From discovery to clinical use
Topics Anticancer Agents
Personalised/Precision Medicine
Thoracic Malignancies
Presenter Tony S.K. Mok
Authors T.S.K. Mok
  • Clinical Oncology, Prince of Wales Hospital, N/A - Shatin/HK